IPO Boutique

Annexon, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...



For IPO Boutique's "scale of 1 to 5" BUY rating on Annexon, Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Annexon, Inc.ANNX -
NASDAQ
$15.00-$16.00 $17.00 $17.4014.75 million7/24/2020
JP Morgan, BofA Securities, Cowen
Co-Manager(s):
Health Care
Filing(s):

Filed 2020-07-02
Terms Added 2020-07-20
Terms Changed 2020-07-23



Annexon, Inc. Quote & Chart - Click for current quote - ANNX

About Annexon, Inc. (adapted from Annexon, Inc. prospectus):
They are a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "ANNX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved